SCHEMBL7703145

SCHEMBL7703145

CSCN1CSC(Cc2cc(C(C)(C)C)c(O)c(C(C)(C)C)c2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.40
GAA P10253 6/20 0.40
KDM4E B2RXH2 4/20 0.40
TSHR P16473 5/20 0.40
MAPT P10636 4/20 0.40
TDP1 Q9NUW8 2/20 0.40
HSD17B10 Q99714 1/20 0.40
LMNA P02545 3/20 0.38
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38
HPGD P15428 1/20 0.38
PKM P14618 1/20 0.37
HTT P42858 1/20 0.37
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
CYP1A2 P05177 3/20 0.36
CYP3A4 P08684 2/20 0.36
MAPK1 P28482 2/20 0.36
BLM P54132 2/20 0.36
ATM Q13315 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8532155 0.83 ALDH1A1 (0.44) ALDH1A1GAAKDM4ETSHRMAPT
SCHEMBL7563154 0.82 MAOB (0.46) ALDH1A1GAAKDM4ETSHRMAPT
SCHEMBL8532773 0.78 ALDH1A1 (0.38) ALDH1A1GAAKDM4ETSHRMAPT
SCHEMBL8533919 0.78 GAA (0.42) ALDH1A1GAAKDM4ETSHRMAPT
SCHEMBL8933311 0.76 ALDH1A1 (0.40) ALDH1A1GAAKDM4ETSHRMAPT
SCHEMBL7796811 0.76 ALDH1A1 (0.46) ALDH1A1GAAKDM4ETSHRMAPT
SCHEMBL7560742 0.76 CACNA1A (0.43) ALDH1A1GAAKDM4ETSHRMAPT
SCHEMBL7561509 0.75 KMT2A (0.39) ALDH1A1GAAKDM4ETSHRTDP1
SCHEMBL8936886 0.75 KMT2A (0.39) ALDH1A1GAAKDM4ETSHRTDP1
SCHEMBL7561512 0.75 KMT2A (0.39) ALDH1A1GAAKDM4ETSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420428-B1 TREATING HEPATITIS C AND HEPATIC FIBROSIS USING 2,6-DI-TERT-BUTYLPHENOL DERIVATIVES; EFFECTIVE IN SUBJECTS WITH INTERFERON INSUSCEPTIBILITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-07-16 US disclosed
US-6369097-B1 Treatment and prevention of hepatic disorders THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-04-09 US disclosed
US-6348493-B1 TREATMENT OF HEPATITIS C BY ADMINISTERING 2,6-DI-TER-BUTYLPHENOL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-02-19 US disclosed
US-6218437-B1 ADMINISTERING A THERAPEUTIC AMOUNT OF DI-TERT-BUTYLPHENOL DERIVATIVE TO SUBJECT UNDER CONDITIONS SUCH THAT SAID SYMPTOMS ARE DIMINISHED THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-04-17 US disclosed
WO-2001021166-A1 TREATMENT AND PREVENTION OF HEPATIC DISORDERS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-03-29 WO disclosed
US-5691367-A ANTIINFLAMMATORY AGENTS OR ANTIARTHRITIC AGENTS ELI LILLY AND COMPANY (US) 1997-11-25 US disclosed
EP-0722729-A2 Aryl-substituted rhodanines for treating multiple sclerosis ELI LILLY AND COMPANY (US) 1996-07-24 EP disclosed
US-5356917-A Antiischemic, antiinflammatory, antiarthritic agents, treat-ment of dystrophic mammals ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
US-5158966-A Aryl-substituted rhodanine derivatives THE UNIVERSITY OF COLORADO FOUNDATION, INC. (US) 1992-10-27 US disclosed